Your Search Returned 166 tagged news reports
At first blush, Washington's tough talk about fiscal austerity doesn't look good for drug makers. Government programs including Medicare and Medicaid spend $99 billion each year on prescription medicines, according to Washington consulting firm
two of the largest generic-drug makers, released solid earnings this week...The way the generic-drug system works in the U.S., the first generic-drug maker to challenge a patent on a brand-name drug is granted a six-month exclusivity period.
The dividing line between the big generic and brand-name drug makers is increasingly fuzzy...Big Pharma developed new drugs, while generic companies like Teva copied these medicines once their patent protection expired...Teva is defending a brand-
Eli Lilly and Co., already watching as U.S. health-care reform cuts into revenue, says any deeper cuts in federal drug programs would have a "profound impact" on the company. Budget negotiators in Washington are considering numerous cuts in Medicare
No longer will their cholesterol -lowering pills be oblong and white. If they choose a generic alternative, their pills will be anything but that color and shape, and their appearance may change from refill to refill as pharmacists switch among
And with pressure growing to cut federal support for state Medicaid programs and to force seniors on Medicare to pay more for their care, many liberal lawmakers are demanding that pharmaceutical companies chip in more, as well. "To let pharmaceutical
Just five months after Cadence Pharmaceuticals started selling its first approved prescription drug, the San Diego company is facing potential competition from a pharmaceutical company that wants to sell a lower-priced, generic version of Ofirmev, an
The justices in a 5-4 ruling said generic drug companies do not share the same level of responsibility as makers of brand-name equivalents, to update their warning labels when significant new risks emerge. The financial and safety implications from
Inc. and other generic drug manufacturers. She alleges that taking metoclopramide gave her a severe neurological movement disorder, but none of the generic drug's manufacturers and distributors made any effort to include warnings
When a patient comes in and asks for Viagra, will you first screen for low T?" meaning testosterone. The pitch by Solvay Pharmaceuticals Inc. was part of its effort to make its testosterone replacement drug AndroGel "ride (the) coat tails of Viagra."